摘要
The pathway for creating and seeing a medical device to market is time-intensive,costly,and demanding[1,2].This is particularly true of devices developed with tissue engineering components within the device[1,3].Machine learning and artificial intelligence have expedited optimization and engineering design in many other engineering disciplines[4,5].
基金
the National Institutes of Health(P41 EB023833 and R01 AR068073).
